NEO SV 01
Alternative Names: NEO-SV-01Latest Information Update: 28 Sep 2022
At a glance
- Originator Neon Therapeutics
- Developer BioNTech
- Class Cancer vaccines; Peptide vaccines
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer